Lumida
/IRWD
⌘K
Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc

IRWD
$3.86USD-0.26%-0.01 today

MARKET CAP

635.4M

P/E (TTM)

6.3x

FWD P/E

3.2x

DAY RANGE

$4 – $4

52W RANGE

$1
$6

AI Summary

Stalk
Sell NowHigh

IRWD remains in a Stage 4 decline with confirmed lower highs and lower lows under a bearish EMA regime. Price is trading below the down-sloping 9 and 21 EMAs and is now pulling back toward the 50 DMA without evidence of selling exhaustion or stabilization. The medium-term bias is bearish, permitting only sell-side engagement. Execution should focus on Sell Now into rallies to the 9/21 EMA resistance and recent horizontal levels.

  • Linzess net sales $272.5m in Q1 2026, up 97% YoY.
  • Apraglutide Phase 3 STARS-2 trial underway; peak sales forecast >$1B.
  • Profitability under pressure from pricing cuts and rising costs.
Full analysis →
Insider Trades41 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 7, 2026SellIRWDRonald SilverPFO & PAO127,890$4.52$635.4M-33.22%+439.86%$578.1K-28.96%10b5-1Stalk
Feb 23, 2026SellIRWDTammi L GaskinsChief Commercial Officer21,526$3.73$635.4M-33.22%+439.86%$80.3K-4.68%Stalk
Feb 23, 2026SellIRWDGregory S. MartiniChief Financial Officer21,944$3.73$635.4M-33.22%+439.86%$81.9K-6.19%Stalk
Feb 23, 2026SellIRWDRonald SilverPrincipal Accounting Officer24,173$3.73$635.4M-33.22%+439.86%$90.2K-4.46%Stalk
Feb 23, 2026SellIRWDMichael ShetzlineSVP, CMO, Head-Res&Drug32,582$3.73$635.4M-33.22%+439.86%$121.6K-2.98%Stalk
Feb 23, 2026SellIRWDMinardo JohnChief Legal Officer36,492$3.73$635.4M-33.22%+439.86%$136.2K-4.66%Stalk
Feb 23, 2026SellIRWDThomas A MccourtChief Executive Officer198,283$3.73$635.4M-33.22%+439.86%$739.9K-6.05%Stalk
Jan 5, 2026SellIRWDRonald SilverPrincipal Accounting Officer35,416$4.60$635.4M-33.22%+439.86%$162.9K-11.34%10b5-1Stalk
Nov 17, 2025SellIRWDTammi L GaskinsChief Commercial Officer6,016$3.32$635.4M-33.22%+439.86%$20.0K-2.49%Stalk
Aug 11, 2025SellIRWDGregory S. MartiniChief Financial Officer1,265$0.84$635.4M-33.22%+439.86%$1.1K-0.69%Stalk
Aug 11, 2025SellIRWDTammi L GaskinsChief Commercial Officer1,316$0.84$635.4M-33.22%+439.86%$1.1K-0.54%Stalk
Aug 11, 2025SellIRWDRonald SilverPrincipal Accounting Officer2,846$0.84$635.4M-33.22%+439.86%$2.4K-1.02%Stalk
Aug 11, 2025SellIRWDMinardo JohnChief Legal Officer7,754$0.84$635.4M-33.22%+439.86%$6.5K-1.90%Stalk
May 16, 2025SellIRWDTammi L GaskinsChief Commercial Officer2,563$0.58$635.4M-33.22%+439.86%$1.5K-1.05%Stalk
May 16, 2025SellIRWDThomas A MccourtChief Executive Officer13,353$0.58$635.4M-33.22%+439.86%$7.7K-1.15%Stalk
Feb 10, 2025SellIRWDRonald SilverPrincipal Accounting Officer12,048$1.76$635.4M-33.22%+439.86%$21.2K-4.13%Stalk
Feb 10, 2025SellIRWDGregory S. MartiniChief Financial Officer12,052$1.76$635.4M-33.22%+439.86%$21.2K-6.15%Stalk
Feb 10, 2025SellIRWDMinardo JohnChief Legal Officer38,938$1.76$635.4M-33.22%+439.86%$68.5K-8.71%Stalk
Feb 10, 2025SellIRWDMichael ShetzlineSVP, CMO, Head-Res&Drug41,269$1.76$635.4M-33.22%+439.86%$72.6K-6.93%Stalk
Feb 10, 2025SellIRWDThomas A MccourtChief Executive Officer139,064$1.76$635.4M-33.22%+439.86%$244.8K-10.70%Stalk
Nov 18, 2024SellIRWDAndrew DavisSVP, Chief Business Officer5,360$4.08$635.4M-33.22%+439.86%$21.9K-1.85%Stalk
Nov 18, 2024SellIRWDSravan Kumar EmanySVP, COO and CFO11,001$4.08$635.4M-33.22%+439.86%$44.9K-3.43%Stalk
Aug 12, 2024SellIRWDRonald SilverPrincipal Accounting Officer3,107$4.27$635.4M-33.22%+439.86%$13.3K-1.92%Stalk
Aug 12, 2024SellIRWDMinardo JohnChief Legal Officer9,910$4.27$635.4M-33.22%+439.86%$42.3K-3.36%Stalk
May 20, 2024SellIRWDMichael ShetzlineCMO,SVP,Head-Res&Drug16,128$6.45$635.4M-33.22%+439.86%$104.0K-3.75%Stalk
May 20, 2024SellIRWDMinardo JohnChief Legal Officer17,404$6.45$635.4M-33.22%+439.86%$112.3K-5.58%Stalk
May 20, 2024SellIRWDAndrew DavisSVP, Chief Business Officer22,725$6.45$635.4M-33.22%+439.86%$146.6K-7.31%Stalk
May 20, 2024SellIRWDThomas A MccourtChief Executive Officer67,618$6.45$635.4M-33.22%+439.86%$436.1K-5.55%Stalk
May 16, 2024SellIRWDSravan Kumar EmanySVP, Chief Financial Officer18,280$6.64$635.4M-33.22%+439.86%$121.4K-5.39%Stalk
Mar 4, 2024BuyIRWDSravan Kumar EmanySVP, Chief Financial Officer10,684$9.38$635.4M-33.22%+439.86%$100.2K+3.67%Stalk
Feb 12, 2024SellIRWDRonald SilverPrincipal Accounting Officer7,908$15.24$635.4M-33.22%+439.86%$120.5K-5.56%Stalk
Feb 12, 2024SellIRWDAndrew DavisSVP, Chief Business Officer9,846$15.24$635.4M-33.22%+439.86%$150.1K-3.93%Stalk
Feb 12, 2024SellIRWDMichael ShetzlineCMO,SVP,Head-Res&Drug38,618$15.24$635.4M-33.22%+439.86%$588.5K-9.50%Stalk
Feb 12, 2024SellIRWDMinardo JohnChief Legal Officer47,380$15.24$635.4M-33.22%+439.86%$722.1K-15.83%Stalk
Feb 12, 2024SellIRWDThomas A MccourtChief Executive Officer177,164$15.24$635.4M-33.22%+439.86%$2.7M-17.54%Stalk
Feb 8, 2024SellIRWDSravan Kumar EmanySVP, Chief Financial Officer41,332$14.90$635.4M-33.22%+439.86%$615.8K-15.48%Stalk
Nov 20, 2023SellIRWDAndrew DavisSVP, Chief Business Officer3,287$9.69$635.4M-33.22%+439.86%$31.9K-1.49%Stalk
Nov 16, 2023SellIRWDSravan Kumar EmanySVP, Chief Financial Officer6,661$9.44$635.4M-33.22%+439.86%$62.9K-3.53%Stalk
Sep 15, 2023BuyIRWDSravan Kumar EmanySVP, Chief Financial Officer36,072$8.32$635.4M-33.22%+439.86%$300.1K+23.63%Stalk
Aug 14, 2023SellIRWDRonald SilverPrincipal Accounting Officer1,976$10.04$635.4M-33.22%+439.86%$19.8K-1.45%Stalk
Aug 14, 2023SellIRWDMinardo JohnChief Legal Officer7,045$10.04$635.4M-33.22%+439.86%$70.7K-3.54%Stalk